CRISPR Therapeutics AG Income Statement (2015-2026) | CRSP

Income Statement Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
76.46M76.99M77.39M77.79M78.25M78.51M78.86M79.37M79.43M80.04M84.84M85.05M85.34M85.74M86.36M88.38M93.87M95.89M96.39M96.66M
Revenue & cost
Revenue (Quarter)
0.82M12.90M0.94M0.16M0.09M0.01M100.00M70.00M201.21M0.50M0.52M0.60M35.69M0.86M0.89M0.89M0.86M1.46M10.18M
Operating items
Research & Development (Quarter)
83.50M103.09M118.25M123.22M116.62M103.56M99.94M101.56M90.70M95.14M76.17M80.17M82.16M71.74M72.48M69.89M58.90M13.00M68.57M67.15M
Selling, General & Administrative (Quarter)
23.71M23.68M28.02M26.27M27.00M21.17M22.36M19.03M18.29M16.48M17.95M19.48M17.42M18.12M19.30M18.92M16.93M18.40M17.18M17.55M
Other Operating Expenses (Quarter)
22.46M31.82M30.65M33.92M38.86M6.82M42.19M44.64M23.42M20.00M46.97M52.13M11.15M10.42M57.51M141.41M57.12M124.23M45.95M42.74M
Operating Expenses (Quarter)
129.67M158.60M176.91M183.42M182.48M131.55M164.49M165.22M132.41M131.62M141.09M151.78M110.73M100.28M149.29M230.22M132.95M155.63M131.71M127.45M
Operating Income (Quarter)
-128.85M-145.70M-175.97M-183.26M-182.39M-131.54M-64.49M-95.22M-132.41M69.58M-140.59M-151.26M-110.13M-64.59M-148.42M-229.32M-132.06M-154.76M-130.25M-117.27M
EBIT (Quarter)
-128.85M-145.70M-175.97M-183.26M-182.39M-131.54M-64.49M-95.22M-132.41M69.58M-140.59M-151.26M-110.13M-64.59M-148.42M-229.32M-132.06M-154.76M-130.25M-117.27M
Non-operating items
Interest & Investment Income (Quarter)
-0.12M-4.30M-11.80M-3.38M-1.82M6.50M6.23M0.45M2.16M8.65M-3.45M-1.33M13.37M-8.64M2.25M-0.17M0.97M-0.17M-6.73M-2.69M
Other Non Operating Income (Quarter)
1.10M2.20M0.36M3.54M7.26M11.49M12.74M18.41M20.67M20.00M24.72M26.14M25.06M27.98M13.54M22.07M26.24M24.77M8.16M27.07M
Non Operating Income (Quarter)
1.10M2.20M0.36M3.54M7.26M11.49M12.74M18.41M20.67M20.00M24.72M26.14M25.06M27.98M13.54M22.07M26.24M24.77M8.16M27.07M
Net income details
EBT (Quarter)
-127.75M-143.50M-175.61M-179.72M-175.12M-120.05M-51.74M-76.82M-111.74M89.58M-115.87M-125.12M-85.07M367.29M-134.89M-207.26M-105.82M-162.53M-122.09M-90.19M
Tax Provisions (Quarter)
-0.60M-2.25M3.61M6.10M-0.57M-9.48M1.32M0.92M0.40M0.19M0.72M1.30M0.88M0.70M1.10M1.29M0.62M-0.28M0.84M1.00M
Profit After Tax (Quarter)
-127.15M-141.25M-179.22M-185.83M-174.55M-103.96M-53.06M-77.74M-112.15M89.35M-116.59M-126.41M-72.50M-45.96M-133.70M-208.55M-106.44M-127.63M-129.69M-93.84M
Equity Income (Quarter)
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)
-127.15M-141.25M-179.22M-185.82M-174.55M-110.58M-53.06M-77.74M-112.14M89.39M-116.59M-126.42M-85.94M366.59M-135.99M-208.55M-106.44M-162.25M-122.93M-91.19M
Consolidated Net Income (Quarter)
-127.15M-141.25M-179.22M-185.82M-174.55M-110.58M-53.06M-77.74M-112.14M89.39M-116.59M-126.42M-85.94M366.59M-135.99M-208.55M-106.44M-162.25M-122.93M-91.19M
Income towards Parent Company (Quarter)
-127.15M-141.25M-179.22M-185.82M-174.55M-110.58M-53.06M-77.74M-112.14M89.39M-116.59M-126.42M-85.94M366.59M-135.99M-208.55M-106.44M-162.25M-122.93M-91.19M
Net Income towards Common Stockholders (Quarter)
-127.15M-141.25M-179.22M-185.82M-174.55M-110.58M-53.06M-77.74M-112.14M89.39M-116.59M-126.42M-85.94M366.59M-135.99M-208.55M-106.44M-162.25M-122.93M-91.19M
Additional items
EPS (Basic) (Quarter)
-1.67-1.86-2.32-2.40-2.24-1.42-0.67-0.98-1.411.13-1.43-1.49-1.014.35-1.58-2.40-1.17-1.80-1.28-0.94
EPS (Diluted) (Quarter)
-1.67-1.76-2.32-2.40-2.24-1.42-0.67-0.98-1.411.13-1.43-1.49-1.014.35-1.58-2.40-1.17-1.80-1.28-0.94
Shares Outstanding (Quarter)
76.29M75.95M77.10M77.51M78.02M77.75M78.68M79.09M79.41M79.22M81.79M84.92M85.23M84.36M85.94M87.07M91.31M89.93M96.05M96.51M
Shares Outstanding (Diluted) (Quarter)
76.29M80.39M77.10M77.51M78.02M77.75M78.68M79.09M79.41M79.22M81.79M84.92M85.23M84.36M85.94M87.07M91.31M89.93M96.05M96.51M
EBITDA (Quarter)
-128.85M-145.70M-175.97M-183.26M-182.39M-131.54M-64.49M-95.22M-132.41M69.58M-140.59M-151.26M-110.13M-64.59M-148.42M-229.32M-132.06M-154.76M-130.25M
Interest Expenses (Quarter)
0.96M219.10M16.91M20.26M22.12M198.28M10.61M9.44M7.06M115.68M2.84M3.53M0.23M14.05M0.47M0.11M0.20M14.53M
Tax Rate (Quarter)
0.471.57-2.05-3.390.337.89-2.55-1.20-0.360.21-0.62-1.04-1.030.19-0.82-0.62-0.580.17-0.69